Free Trial

Cabot Corporation (NYSE:CBT) Stock Holdings Lifted by Paradiem LLC

Cabot logo with Basic Materials background

Paradiem LLC boosted its stake in shares of Cabot Corporation (NYSE:CBT - Free Report) by 24.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 165,055 shares of the specialty chemicals company's stock after buying an additional 32,780 shares during the quarter. Cabot accounts for approximately 3.8% of Paradiem LLC's portfolio, making the stock its 3rd largest holding. Paradiem LLC owned 0.30% of Cabot worth $13,723,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CBT. EverSource Wealth Advisors LLC lifted its stake in shares of Cabot by 37.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after buying an additional 219 shares during the period. Curat Global LLC purchased a new position in shares of Cabot in the 1st quarter valued at $83,000. Farther Finance Advisors LLC grew its holdings in Cabot by 1,346.4% during the 1st quarter. Farther Finance Advisors LLC now owns 1,620 shares of the specialty chemicals company's stock valued at $136,000 after purchasing an additional 1,508 shares in the last quarter. GAMMA Investing LLC grew its holdings in Cabot by 26.1% during the 1st quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company's stock valued at $141,000 after purchasing an additional 352 shares in the last quarter. Finally, GeoWealth Management LLC grew its holdings in Cabot by 4,553.6% during the 4th quarter. GeoWealth Management LLC now owns 2,606 shares of the specialty chemicals company's stock valued at $238,000 after purchasing an additional 2,550 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have weighed in on CBT shares. UBS Group decreased their price objective on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a report on Monday, April 7th. Wall Street Zen downgraded shares of Cabot from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th.

Read Our Latest Stock Analysis on Cabot

Cabot Stock Performance

NYSE:CBT traded up $0.06 during mid-day trading on Friday, hitting $73.15. The stock had a trading volume of 655,816 shares, compared to its average volume of 410,231. The stock has a market capitalization of $3.93 billion, a price-to-earnings ratio of 9.46, a P/E/G ratio of 0.66 and a beta of 0.87. The company has a 50 day simple moving average of $76.01 and a 200-day simple moving average of $83.74. Cabot Corporation has a 52 week low of $71.64 and a 52 week high of $117.46. The company has a current ratio of 1.96, a quick ratio of 1.30 and a debt-to-equity ratio of 0.69.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 EPS for the quarter, topping analysts' consensus estimates of $1.86 by $0.04. Cabot had a net margin of 11.08% and a return on equity of 26.76%. The company had revenue of $936.00 million for the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the previous year, the firm earned $1.78 EPS. Cabot's revenue was down 8.1% on a year-over-year basis. On average, research analysts expect that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 30th were paid a $0.45 dividend. The ex-dividend date of this dividend was Friday, May 30th. This represents a $1.80 annualized dividend and a dividend yield of 2.46%. This is a boost from Cabot's previous quarterly dividend of $0.43. Cabot's payout ratio is currently 23.29%.

About Cabot

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

See Also

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines